Professional Medical Expertise Company (TADAWUL:9574)
Saudi Arabia · Delayed Price · Currency is SAR 87.05
-1.90 (-2.14%)
Sep 2, 2026, 3:10 PM AST
TADAWUL:9574 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 441.45 | 418.78 | 313.17 | 250.12 | 176.05 | 131.26 | |
Revenue Growth | 24.07% | 33.72% | 25.21% | 42.07% | 34.13% | 76.39% |
Cost of Revenue | 233.79 | 233.79 | 174.37 | 138.15 | 92.4 | 64.35 |
Gross Profit | 207.66 | 184.99 | 138.8 | 111.96 | 83.65 | 66.91 |
Selling, General & Admin | 121.9 | 121.9 | 95.65 | 76.1 | 55.35 | 42.02 |
Operating Expenses | 145.62 | 125.22 | 99.45 | 78.9 | 57.75 | 42.46 |
Operating Income | 62.04 | 59.77 | 39.35 | 33.07 | 25.9 | 24.45 |
Interest Expense | -11.61 | -11.61 | -10.82 | -6.65 | -0.1 | - |
Currency Exchange Gain (Loss) | -3.5 | -3.5 | -1.89 | -0.57 | - | - |
Other Non Operating Income (Expenses) | 1.86 | 1.86 | 3.37 | 0.27 | -4.93 | -2.64 |
EBT Excluding Unusual Items | 48.78 | 46.51 | 30 | 26.12 | 20.87 | 21.81 |
Gain (Loss) on Sale of Assets | - | - | - | 1.09 | - | - |
Asset Writedown | -0.84 | -0.84 | - | - | - | - |
Pretax Income | 47.94 | 45.67 | 30 | 27.22 | 20.87 | 21.81 |
Income Tax Expense | 4.03 | 3.97 | 2.36 | 2.37 | 1.85 | 1.19 |
Earnings From Continuing Operations | 43.91 | 41.7 | 27.64 | 24.84 | 19.02 | 20.62 |
Minority Interest in Earnings | 0.01 | 0.01 | 0.01 | -0 | - | - |
Net Income | 43.92 | 41.71 | 27.65 | 24.84 | 19.02 | 20.62 |
Net Income to Common | 43.92 | 41.71 | 27.65 | 24.84 | 19.02 | 20.62 |
Net Income Growth | 16.66% | 50.84% | 11.29% | 30.65% | -7.78% | 121.80% |
Shares Outstanding (Basic) | - | 4 | 4 | 4 | 2 | 1 |
Shares Outstanding (Diluted) | - | 4 | 4 | 4 | 2 | 1 |
Shares Change | - | - | - | 56.73% | 189.51% | - |
EPS (Basic) | - | 11.92 | 7.90 | 7.10 | 8.52 | 26.73 |
EPS (Diluted) | - | 11.92 | 7.90 | 7.10 | 8.52 | 26.73 |
EPS Growth | - | 50.84% | 11.29% | -16.64% | -68.14% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 9.59 | -23.52 | -8.46 | -3.1 | -10.43 | 17.69 |
Free Cash Flow Per Share | - | -6.72 | -2.42 | -0.89 | -4.67 | 22.93 |
Dividend Per Share | - | - | 1.000 | - | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 47.04% | 44.17% | 44.32% | 44.77% | 47.51% | 50.98% |
Operating Margin | 14.05% | 14.27% | 12.57% | 13.22% | 14.71% | 18.63% |
Profit Margin | 9.95% | 9.96% | 8.83% | 9.93% | 10.80% | 15.71% |
Free Cash Flow Margin | 2.17% | -5.62% | -2.70% | -1.24% | -5.93% | 13.48% |
EBITDA | 68.65 | 66.04 | 44.25 | 37.06 | 27.96 | 26.25 |
EBITDA Margin | 15.55% | 15.77% | 14.13% | 14.82% | 15.88% | 20.00% |
D&A For EBITDA | 6.61 | 6.27 | 4.89 | 3.99 | 2.06 | 1.79 |
EBIT | 62.04 | 59.77 | 39.35 | 33.07 | 25.9 | 24.45 |
EBIT Margin | 14.05% | 14.27% | 12.57% | 13.22% | 14.71% | 18.63% |
Effective Tax Rate | 8.41% | 8.70% | 7.87% | 8.72% | 8.88% | 5.46% |